Journal article icon

Journal article

Advances in anticancer radiopharmaceuticals.

Abstract:

This review highlights recent progress in the development of anticancer radiopharmaceuticals. Molecularly targeted radiotherapy refers to the selective delivery of radionuclides that emit charged particles, such as α particles, β or Auger electrons, to cancer cells via a targeting vector. The discovery of new molecular targets through systems biology and other approaches has widened the scope for radiopharmaceutical development. Innovations in antibody engineering and humanisation, recombinan...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1016/j.clon.2013.06.004

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Oncology
Role:
Author
Journal:
Clinical oncology (Royal College of Radiologists (Great Britain))
Volume:
25
Issue:
10
Pages:
604-609
Publication date:
2013-10-05
DOI:
EISSN:
1433-2981
ISSN:
0936-6555
URN:
uuid:22d99eb6-1f98-44e9-a51e-7f4f9c9518f5
Source identifiers:
414755
Local pid:
pubs:414755

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP